Skip to content

Russia proposes free diabetes medication for working-age patients at risk

A bold reform could save 105,000 Russians from financial ruin and job loss. Why their health is now an economic priority.

The image shows a poster with a flowchart depicting the different types of people who have been...
The image shows a poster with a flowchart depicting the different types of people who have been diagnosed with cancer. The text on the poster reads "Benefits and Services for Low-income Individuals". The flowchart is divided into sections, each representing a different type of health care provider, such as Medicare, Medicaid, and Social Security. Each section is further divided into subsections, with arrows connecting them to indicate the flow of information. The poster also includes a legend at the bottom that explains the meaning of each section.

Russia proposes free diabetes medication for working-age patients at risk

Scientists in Russia have proposed changes to the system for providing free medication to patients with type 2 diabetes. The new approach would focus on working-age individuals who lack disability status but face serious health risks. Currently, only disabled patients automatically receive state-funded treatment, leaving many others dependent on inconsistent regional programmes.

The suggested reform targets around 105,000 Russians under 60 who suffer from chronic heart failure, chronic kidney disease, or peripheral artery disease—yet do not qualify as disabled. These conditions often accompany type 2 diabetes and can severely limit a person's ability to work. Out of the country's 5.5 million diabetics, roughly one million require prioritised care under the proposed system.

At present, non-disabled patients rely on regional programmes for free medication. However, these schemes frequently face supply disruptions caused by procurement delays. Many individuals end up paying for their prescriptions out of pocket, while the cost of therapy remains difficult to predict due to varying treatment plans and drug options. Experts argue that investing in the health of working-age patients makes economic sense. By preserving their ability to work, the state could reduce long-term healthcare costs and boost productivity. The goal is to help people regain their health and return to full-time employment rather than relying on disability benefits.

If adopted, the revised system would shift resources toward patients most at risk of losing their jobs due to diabetes-related complications. The focus remains on those without disability status but with conditions that threaten their work capacity. Accurate patient selection and stable drug supply will be key to the programme's success.

Read also:

Latest